Clinical Trial Update: BNT151 as a Monotherapy and in Combination With Other Anti-cancer Agents in Patients With Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 study of BNT151 in monotherapy and in combination with other anti-cancer agents for solid tumors has been terminated, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumor

Drugs mentioned

• BNT151

Snippet

Sponsor: BioNTech SE | Conditions: Solid Tumor | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2025-07-02